Zhejiang Medicine Co., Ltd. (SHA:600216)

China flag China · Delayed Price · Currency is CNY
14.70
+0.09 (0.62%)
Apr 29, 2026, 3:00 PM CST
9.78%
Market Cap 13.85B
Revenue (ttm) 8.82B
Net Income (ttm) 751.31M
Shares Out 947.91M
EPS (ttm) 0.78
PE Ratio 18.70
Forward PE 12.37
Dividend 0.28 (1.92%)
Ex-Dividend Date Jul 21, 2025
Volume 15,322,149
Average Volume 26,263,823
Open 14.53
Previous Close 14.61
Day's Range 14.45 - 14.72
52-Week Range 13.29 - 18.58
Beta 0.58
RSI 40.00
Earnings Date Apr 11, 2026

About Zhejiang Medicine

Zhejiang Medicine Co., Ltd. manufactures and sells life nutrition and medical products in China and internationally. The company offers synthetic vitamin E, natural vitamin E, β-carotene, cantharidin, vancomycin hydrochloride, and teicoplanin. It also provides fat-soluble vitamins, retinoids, quinolone antibiotics, anti-resistance antibiotics, and other products, as well as animal nutrition products. In addition, the company offers injectable levofloxacin lactate, injectable vancomycin hydrochloride injections, and injectable teicoplanin produc... [Read more]

Sector Healthcare
Founded 1997
Employees 5,815
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600216
Full Company Profile

Financial Performance

In 2025, Zhejiang Medicine's revenue was 8.88 billion, a decrease of -5.28% compared to the previous year's 9.38 billion. Earnings were 873.38 million, a decrease of -24.74%.

Financial Statements

News

There is no news available yet.